Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
doi: 10.3233/JAD-190237 142 ParthsarathyVHolscherC
Astaxanthin: Membrane Shield Spans the full cell membrane bilayer, neutralizing free radicals at both surfaces
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: a dose-escalation phase I study
aureus (p = 0.002) and a 38% increase against E
The REMAIN-1 Pivotal Cohort has completed enrollment, and the Company remains on track to randomize patients in early 2026 and deliver 6-month topline primary endpoint data and potentially file a PMA in H2 2026
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 26.75
US$ 27.90
US$ 22.50
US$ 24.81
US$ 22.07
US$ 24.18
